Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Activated Protein C Levels Found In Trauma Patients Are Insufficient To Inactivate Platelet Factor Va and Produce Coagulopathy In An In Vitro Model

Michael A Meledeo, PhD, James E Campbell, PhD, Armando C Rodriguez, BS, Melanie V Valenciana, BS, Andrew P Cap, MD,PhD

Blood (2013) 122 (21): 4767.

https://doi.org/10.1182/blood.V122.21.4767.4767

Published: 2013

Journal Articles

Activated Protein C, Sepsis, and the Innate Immune Response to Infection

Hartmut Weiler, PhD, John H. Griffin, PhD

Blood (2012) 120 (21): SCI-43.

https://doi.org/10.1182/blood.V120.21.SCI-43.SCI-43

Published: 2012

Journal Articles

Activated Protein C and Septic Shock: A Propensity-Matched Cohort Study,

Emily K. Rimmer, MD, Anand Kumar, MD, Steve Doucette, MSc, John Marshall, MD, Sandra Dial, MD, David Gurka, MD, Phillip Dellinger, MD, Sat Sharma, MD, Charles Penner, MD, Andreas Kramer, MD, Kenneth Wood, MD, John Ronald, MD, Ryan Zarychanski, MD, MSc

Blood (2011) 118 (21): 3307.

https://doi.org/10.1182/blood.V118.21.3307.3307

Published: 2011

Journal Articles

Recombinant human activated protein C inhibits integrin-mediated neutrophil migration

Gwendolyn F. Elphick, Pranita P. Sarangi, Young-Min Hyun, Joseph A. Hollenbaugh, Alfred Ayala, Walter L. Biffl, Hung-Li Chung, Alireza R. Rezaie, James L. McGrath, David J. Topham, Jonathan S. Reichner, Minsoo Kim

Blood (2009) 113 (17): 4078–4085.

https://doi.org/10.1182/blood-2008-09-180968

Published: 2009

Includes: Multimedia, Supplemental data

Journal Articles

Dissemenated Intravascular Coagulation in Patients with Septic Shock: Impact of Coagulation Markers on Prediction of the Mortality

Geraldine Lavigne-Lissalde, Christophe CC Combescures, Sr., Laurent LM Muller, Sr., Christian CB Bengler, Sr., Françoise FC Casano, jean-Yves JYL Lefrant, Sr., jean-Christophe JCG Gris, Sr.

Blood (2008) 112 (11): 4102.

https://doi.org/10.1182/blood.V112.11.4102.4102

Published: 2008

Journal Articles

An Ex Vivo Perfusion Model To Study the Treatment of Thrombotic Microangiopathy during Pig-to-Human Xenogenic Kidney Transplantation.

Wolf Ramackers, Lars Friedrich, MD, Wolfgang Schüttler, PhD, Sabine Bergmann, Arnold Ganser, MD, Michael Winkler, MD, Andreas Tiede, MD, PhD

Blood (2007) 110 (11): 3190.

https://doi.org/10.1182/blood.V110.11.3190.3190

Published: 2007

Journal Articles

Drotrecogin Alfa (Xigris) Induced Coagulopathy as Measured by Routine Lab Tests in a Community Hospital Setting.

Archana Maini, MD, Chudaratna Madangopal, MD, Kishor Sheth, MD

Blood (2005) 106 (11): 4129.

https://doi.org/10.1182/blood.V106.11.4129.4129

Published: 2005

Journal Articles

Recombinant Human Activated Protein C Suppresses Endotoxin Induced Hypotension in Mice Deficient of the Endothelial Protein C Receptor (EPCR).

David E. Joyce, MD, Deborah L. Donahue, BS, Patricia C. Liaw, PhD, Francis J. Castellino, PhD

Blood (2005) 106 (11): 3696.

https://doi.org/10.1182/blood.V106.11.3696.3696

Published: 2005

Journal Articles

Anticoagulant and Anti-Inflammatory Effects of Recombinant Human Antithrombin in Man after LPS Challenge.

Bernd Jilma, MD, Judith M. Leitner, MD, Florian B. Mayr, MD, Christa Firbas, MD, Rosemarie A. Reiter, MD, Peter Kalhs, MD

Blood (2005) 106 (11): 1880.

https://doi.org/10.1182/blood.V106.11.1880.1880

Published: 2005

Journal Articles

A Case of Acquired Hemophilia Post Treatment with Recombinant Human Activated Protein C (rh APC).

Yelena Patsiornik, MD, Archana Maini, MD, Attending.

Blood (2005) 106 (11): 4021.

https://doi.org/10.1182/blood.V106.11.4021.4021

Published: 2005

Journal Articles

Erratum for vol. 104, p. 3878

Blood (2005) 105 (10): 3785.

https://doi.org/10.1182/blood-2005-03-1328

Published: 2005

Journal Articles

Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis

Jerry A. Nick, Christopher D. Coldren, Mark W. Geraci, Katie R. Poch, Brian W. Fouty, James O'Brien, Michael Gruber, Simona Zarini, Robert C. Murphy, Katherine Kuhn, Don Richter, Kelly R. Kast, Edward Abraham

Blood (2004) 104 (13): 3878–3885.

https://doi.org/10.1182/blood-2004-06-2140

Published: 2004

Journal Articles

Challenge with LPS or TNF-α Demonstrates Unique Differences in Primary Arterial Endothelial Cells Pretreated with Recombinant Human Activated Protein C.

James A. Martin, B.S., David E. Joyce, M.D., Rashna Balsara, Ph.D., Victoria A. Ploplis, Ph.D., Francis J. Castellino, Ph.D.

Blood (2004) 104 (11): 1935.

https://doi.org/10.1182/blood.V104.11.1935.1935

Published: 2004

Journal Articles

Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia

Ulla Derhaschnig, Rosemarie Reiter, Paul Knöbl, Magdalena Baumgartner, Priska Keen, Bernd Jilma

Blood (2003) 102 (6): 2093–2098.

https://doi.org/10.1182/blood-2003-02-0416

Published: 2003

NARROW

Activated Protein C Levels Found In Trauma Patients Are Insufficient To Inactivate Platelet Factor Va and Produce Coagulopathy In An In Vitro Model

Activated Protein C, Sepsis, and the Innate Immune Response to Infection

Activated Protein C and Septic Shock: A Propensity-Matched Cohort Study,

Recombinant human activated protein C inhibits integrin-mediated neutrophil migration

Dissemenated Intravascular Coagulation in Patients with Septic Shock: Impact of Coagulation Markers on Prediction of the Mortality

An Ex Vivo Perfusion Model To Study the Treatment of Thrombotic Microangiopathy during Pig-to-Human Xenogenic Kidney Transplantation.

Drotrecogin Alfa (Xigris) Induced Coagulopathy as Measured by Routine Lab Tests in a Community Hospital Setting.

Recombinant Human Activated Protein C Suppresses Endotoxin Induced Hypotension in Mice Deficient of the Endothelial Protein C Receptor (EPCR).

Anticoagulant and Anti-Inflammatory Effects of Recombinant Human Antithrombin in Man after LPS Challenge.

A Case of Acquired Hemophilia Post Treatment with Recombinant Human Activated Protein C (rh APC).

Erratum for vol. 104, p. 3878

Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis

Challenge with LPS or TNF-α Demonstrates Unique Differences in Primary Arterial Endothelial Cells Pretreated with Recombinant Human Activated Protein C.

Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only